News
The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...
Novavax faces a setback as the FDA requests an additional trial for COVID-19 vaccine approval. Read more here.
Federal regulators are asking Novavax to complete an additional clinical trial on its Covid-19 vaccine after previously ...
A new randomized study could cost Novavax tens of millions of dollars, vaccine experts say ...
Novo Nordisk has notched a major legal win against compounding pharmacies that make copies of its diabetes and obesity drug ...
Pharmalittle: We’re reading about the FDA and revolving doors, a Novo win over compounders, and more
Scores of FDA employees are searching for an exit from an agency in turmoil, especially staffers tasked with reviewing drug ...
The FDA is phasing out animal testing and moving to more human-relevant methods. This was announced as one of Marty Makary’s ...
The first wave of Stelara (ustekinumab) biosimilars show steep Wholesale Acquisition Cost discounts greater than 80%, the ...
DelveInsight’s, “Metastatic Colorectal Cancer Pipeline Insight 2025” report provides comprehensive insights about 150+ ...
AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex for the treatment of multiple therapeutic ...
Analytical laboratory testing plays a pivotal role in every stage of drug development and manufacturing. From route design and optimization to clinical trials and ultimately the finished product, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results